Variant report
Variant | nsv960845 |
---|---|
Chromosome Location | chr19:42300606-42302431 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:61)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:42301993-42302045 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr19:42301580-42301625 | Fibrobl | skin: | n/a | n/a |
3 | CTCF | chr19:42301971-42302071 | K562 | blood: | n/a | n/a |
4 | POLR2A | chr19:42301772-42301912 | ProgFib | skin: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:42300812-42300862 | K562 | blood: | n/a |
2 | chr19:42300812-42300862 | SAEC | small airway: | n/a |
3 | chr19:42300812-42300862 | Jurkat | blood: | n/a |
4 | chr19:42300812-42300862 | Caco-2 | colon: | n/a |
5 | chr19:42300812-42300862 | U87 | brain: | n/a |
6 | chr19:42300812-42300862 | HCT-116 | colon: | n/a |
7 | chr19:42300812-42300862 | NHDF-neo | bronchial: | n/a |
8 | chr19:42300812-42300862 | ovcar-3 | ovarian: | n/a |
9 | chr19:42300812-42300862 | SK-N-SH_RA | brain: | n/a |
10 | chr19:42300812-42300862 | ProgFib | skin: | n/a |
11 | chr19:42300812-42300862 | BJ | skin: | n/a |
12 | chr19:42300812-42300862 | HRPEpiC | eye: | n/a |
13 | chr19:42300812-42300862 | MCF-7 | breast: | n/a |
14 | chr19:42300812-42300862 | LNCaP | prostate: | n/a |
15 | chr19:42300812-42300862 | AG04450 | lung: | fetal |
16 | chr19:42300812-42300862 | AoSMC | blood vessel: | n/a |
17 | chr19:42300812-42300862 | AG09319 | gingival: | n/a |
18 | chr19:42300812-42300862 | NH-A | brain: | n/a |
19 | chr19:42300812-42300862 | SKMC | muscle: | n/a |
20 | chr19:42300812-42300862 | HPAEpiC | pulmonary alveolar: | n/a |
21 | chr19:42300812-42300862 | HepG2 | liver: | n/a |
22 | chr19:42300812-42300862 | IMR90 | lung: | fetal |
23 | chr19:42300812-42300862 | HEEpiC | esophagus: | n/a |
24 | chr19:42300812-42300862 | HMEC | breast: | n/a |
25 | chr19:42300812-42300862 | HNPCEpiC | eye: | n/a |
26 | chr19:42300812-42300862 | AG10803 | skin: | n/a |
27 | chr19:42300812-42300862 | NT2-D1 | testis: | n/a |
28 | chr19:42300812-42300862 | HIPEpiC | eye: | n/a |
29 | chr19:42300812-42300862 | HL-60 | blood: | n/a |
30 | chr19:42300812-42300862 | HCM | heart: | n/a |
31 | chr19:42300812-42300862 | Hela-S3 | cervix: | n/a |
32 | chr19:42300812-42300862 | Hepatocyte | liver: | n/a |
33 | chr19:42300812-42300862 | PrEC | prostate: | n/a |
34 | chr19:42300812-42300862 | GM06990 | blood: | n/a |
35 | chr19:42300812-42300862 | GM12892 | blood: | n/a |
36 | chr19:42300812-42300862 | HUVEC | blood vessel: | n/a |
37 | chr19:42300812-42300862 | HEK293 | kidney: | embryo |
38 | chr19:42300812-42300862 | PANC-1 | pancreas: | n/a |
39 | chr19:42300812-42300862 | HCF | heart: | n/a |
40 | chr19:42300812-42300862 | SK-N-MC | brain: | n/a |
41 | chr19:42300812-42300862 | NB4 | blood: | n/a |
42 | chr19:42300812-42300862 | CMK | blood: | n/a |
43 | chr19:42300812-42300862 | GM12891 | blood: | n/a |
44 | chr19:42300812-42300862 | GM12878 | blood: | n/a |
45 | chr19:42300812-42300862 | RPTEC | kidney: | n/a |
46 | chr19:42300812-42300862 | SK-N-SH | brain: | n/a |
47 | chr19:42300812-42300862 | BE2_C | brain: | n/a |
48 | chr19:42300812-42300862 | AG09309 | skin: | n/a |
49 | chr19:42300812-42300862 | HCPEpiC | choroid plexus: | n/a |
50 | chr19:42300812-42300862 | NHBE | bronchial: | n/a |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMRTC2-2 | chr19:42300522-42300673 | NR_102333 |
2 | lnc-DMRTC2-2 | chr19:42301521-42301880 | NR_102333 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEACAM3 | TF binding region |
CEACAM3 | CpG island |
ENSG00000170956 | chromatin interactions |
ENSG00000086548 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs267605503 | chr19:42300612-42300613 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs143094016 | chr19:42300621-42300622 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs1041999 | chr19:42300628-42300629 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs374252282 | chr19:42300636-42300637 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs542097412 | chr19:42300640-42300641 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs377467224 | chr19:42300653-42300654 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs201182929 | chr19:42300656-42300657 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs147069793 | chr19:42300658-42300659 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs530713790 | chr19:42300688-42300689 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs376612840 | chr19:42300707-42300708 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs375545632 | chr19:42300710-42300711 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs189808463 | chr19:42300742-42300743 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs181408377 | chr19:42300746-42300747 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs528149788 | chr19:42300756-42300757 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs546692499 | chr19:42300797-42300798 | Enhancers Flanking Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs567680450 | chr19:42300812-42300813 | Enhancers Flanking Active TSS Active TSS Weak transcription | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs528862598 | chr19:42300825-42300826 | Enhancers Flanking Active TSS Active TSS Weak transcription | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs548470286 | chr19:42300845-42300846 | Enhancers Flanking Active TSS Active TSS Weak transcription | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs570055264 | chr19:42300885-42300886 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs537636801 | chr19:42300901-42300902 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs186216142 | chr19:42300919-42300920 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs55711976 | chr19:42300980-42300981 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs111484024 | chr19:42301028-42301029 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs553435261 | chr19:42301090-42301091 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs189547240 | chr19:42301146-42301147 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs542282768 | chr19:42301153-42301154 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs557275540 | chr19:42301283-42301284 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs56064499 | chr19:42301285-42301286 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs145881379 | chr19:42301316-42301317 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs371663696 | chr19:42301336-42301337 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs535224207 | chr19:42301339-42301340 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs564095742 | chr19:42301346-42301347 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs113179918 | chr19:42301354-42301355 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs181010839 | chr19:42301383-42301384 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs56060480 | chr19:42301412-42301413 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs561494451 | chr19:42301446-42301447 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs528850194 | chr19:42301465-42301466 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs367548029 | chr19:42301487-42301488 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs370207300 | chr19:42301488-42301489 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs368963493 | chr19:42301506-42301507 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs550196605 | chr19:42301512-42301513 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs373917134 | chr19:42301546-42301547 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs563618197 | chr19:42301573-42301574 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs138437996 | chr19:42301591-42301592 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs375018257 | chr19:42301592-42301593 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs141744882 | chr19:42301636-42301637 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs201417987 | chr19:42301651-42301652 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs150578893 | chr19:42301662-42301663 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs199568678 | chr19:42301666-42301667 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs61738270 | chr19:42301685-42301686 | Enhancers Flanking Active TSS Active TSS Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Genital abnormality | 22378287 | CNVD |
Hypospadia | 22378287 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:42290200-42305200 | Weak transcription | Fetal Thymus | thymus |
2 | chr19:42297000-42303000 | Weak transcription | Esophagus | oesophagus |
3 | chr19:42298400-42303600 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr19:42298800-42307400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
5 | chr19:42299000-42305000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr19:42299000-42305200 | Weak transcription | Primary B cells from peripheral blood | blood |
7 | chr19:42299400-42302200 | Weak transcription | GM12878-XiMat | blood |
8 | chr19:42300000-42300800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr19:42300000-42303800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
10 | chr19:42300200-42301600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr19:42300400-42300800 | Flanking Active TSS | Primary B cells from cord blood | blood |
12 | chr19:42300600-42301400 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
13 | chr19:42300800-42303800 | Active TSS | Primary hematopoietic stem cells | blood |
14 | chr19:42300800-42305000 | Active TSS | Primary B cells from cord blood | blood |
15 | chr19:42300800-42305200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
16 | chr19:42301400-42301600 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
17 | chr19:42301600-42305000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
18 | chr19:42301600-42306600 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
19 | chr19:42302200-42303400 | Enhancers | GM12878-XiMat | blood |
20 | chr19:42302400-42303200 | Enhancers | Lung | lung |